国民医疗保健公司
NHC
242.82
-2.71
-1.10%
国民医疗保健公司
US · NHC
#2365 按市值排名
上市于 1970
242.82
-2.71
-1.10%
实时 - 追踪5344个代码 - 心跳于401秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期(2026/Q3)披露持股的机构数量增加了1家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 73.23% +0.03pp
- 机构数量
- 296 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund60.86%
Individual/Insider12.21%
Corporate Pension Plan6.60%
Hedge Fund2.94%
Government Pension Fund1.05%
Public Company1.01%
Private Company0.55%
Insurance Company0.14%
Other14.59%
主要股东 截至 2026-06-30
BlackRock
12.62% · 1.98M 股
National Healthcare Corp., ESOP
6.58% · 1.03M 股
Morgan Stanley Institutional Investment Advisors LLC
6.57% · 1.03M 股
Dimensional Fund Advisors
5.94% · 929.69K 股
Vanguard Portfolio Management, LLC
5.17% · 809.22K 股
First Trust Advisors L.P.
4.66% · 730.57K 股
W. Adams
4.50% · 705.01K 股
Vanguard Capital Management, LLC
4.07% · 637.11K 股
State Street Global Advisors
3.36% · 526.73K 股
Robert Adams
2.83% · 443.92K 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 27次买入 · 23次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| W. Adams | Independent Director | 4.50% |
| Robert Adams | Independent Chairperson | 2.83% |
| Richard LaRoche | Independent Director | 2.30% |
| R. Ussery | President | 1.01% |
| Emil Hassan | Independent Director | 0.42% |
| Stephen Flatt | Chief Executive Officer | 0.42% |
| James Abernathy | Independent Director | 0.28% |
| Brian Kidd | Senior Vice President | 0.15% |
| B. Flatt | Chief Information Officer | 0.10% |
| Vicki Dodson | Senior Vice President of Patient Services | 0.07% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-21 | Vicki Dodson | Senior Vice President of Patient Services | Open Market Disposition | -4,834 | $225.00 |
| 2026-09-10 | Brian Kidd | Senior Vice President | Open Market Disposition | -6,813 | $225.70 |
| 2026-09-09 | Josh McCreary | Senior Vice President | Open Market Disposition | -2,719 | $222.73–225.59 |
| 2026-08-27 | B. Flatt | Chief Information Officer | Open Market Disposition | -7,000 | $221.21–237.18 |
| 2026-08-24 | David Gifford | Independent Director | Open Market Disposition | -1,779 | $225.42 |
| 2026-08-19 | David Gifford | Independent Director | Derivative Exercise and Sale | -4,691 | $171.42–236.75 |
| 2026-08-19 | David Gifford | Independent Director | Derivative Exercise and Retained | +1,788 | $171.42 |
| 2026-08-18 | Stephen Flatt | Chief Executive Officer | Open Market Disposition | -1,500 | $237.08 |
| 2026-08-12 | David Gifford | Independent Director | Derivative Exercise and Retained | +1,021 | $171.42 |
| 2026-06-21 | Emil Hassan | Independent Director | Open Market Disposition | -5,937 | $200.00 |
| 2026-06-15 | Emil Hassan | Independent Director | Open Market Disposition | -1,563 | $199.98 |
| 2026-06-15 | Brian Kidd | Senior Vice President | Other Disposition | -500 | -- |
| 2026-06-07 | Robert Adams | Independent Chairperson | Derivative Exercise and Sale | -4,000 | -- |
| 2026-05-31 | Lisa Piercey | Director | Open Market Acquisition | +949 | $184.26 |
| 2026-05-21 | B. Flatt | Chief Information Officer | Derivative Exercise and Sale | -2,739 | $94.10–196.00 |
| 2026-05-21 | B. Flatt | Chief Information Officer | Derivative Exercise and Retained | +1,261 | $94.10 |
| 2026-05-20 | Richard LaRoche | Independent Director | Open Market Disposition | -7,500 | $195.14 |
| 2026-05-19 | Stephen Flatt | Chief Executive Officer | Other Disposition | -26 | -- |
| 2026-05-18 | Timothy Shelly | Officer | Open Market Disposition | -1,853 | $197.22 |
| 2026-05-13 | Stephen Flatt | Chief Executive Officer | Derivative Exercise and Sale | -4,492 | $90.62–197.96 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
国民医疗保健公司 讨论区 0 条评论